+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Allergy Diagnostics Market by Type (Drug Allergen, Food Allergen, Inhaled Allergen), Product Type (Assay Kits, Consumables, Instruments), Test, End User - Forecast 2023-2030

  • PDF Icon

    Report

  • 193 Pages
  • October 2023
  • Region: Global
  • 360iResearch™
  • ID: 4905051
UP TO OFF until Dec 31st 2023
1h Free Analyst Time

Quick Summary:

In the evolving landscape of healthcare and diagnostics, the Allergy Diagnostics Market stands out as a dynamic field ripe with opportunities for strategic growth. An in-depth market research report has been meticulously structured to provide senior executives with actionable insights into this market's diverse segments. Our examination of the market includes an analysis of the predominant segments such as Drug Allergen and Food Allergen, while also shedding light on market leaders in Product Types and End User categories.

The zest to lead in an enlightened market trajectory and stay abreast of emerging trends is crucial for decision-makers. Hence, this report does not merely quantify the market shares but also provides a qualitative assessment through Market Share Analysis and the FPNV Positioning Matrix. It categorizes vendors into a spectrum of business strategies and product satisfaction, equipping leaders with the acumen to gauge and navigate competitive landscapes. Furthermore, the report offers strategic insights into regional market performances, highlighting areas with burgeoning demand and identifying untapped geographies ripe for penetration and expansion.

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Allergy Diagnostics Market is projected to reach USD 11.80 billion by 2030 from USD 5.41 billion in 2022, at a CAGR of 10.23% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Allergy Diagnostics Market.
  • Based on Type, the market is studied across Drug Allergen, Food Allergen, and Inhaled Allergen. The Drug Allergen commanded largest market share of 29.45% in 2022, followed by Food Allergen.
  • Based on Product Type, the market is studied across Assay Kits, Consumables, and Instruments. The Instruments is further studied across Immunoassay Analyzers and Luminometers. The Consumables commanded largest market share of 39.23% in 2022, followed by Instruments.
  • Based on Test, the market is studied across In-Vitro Tests and In-Vivo Tests. The In-Vitro Tests commanded largest market share of 58.72% in 2022, followed by In-Vivo Tests.
  • Based on End User, the market is studied across Academic Research Institutes, Diagnostic Laboratories, and Hospital-Based Laboratories. The Hospital-Based Laboratories commanded largest market share of 39.97% in 2022, followed by Diagnostic Laboratories.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. Europe, Middle East & Africa commanded largest market share of 40.68% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Allergy Diagnostics Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Allergy Diagnostics Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Allergy Diagnostics Market, highlighting leading vendors and their innovative profiles. These include ALK-Abelló A/S, Allergy Therapeutics PLC, Astra Biotech GmbH, Bausch & Lomb Incorporated, Biomérieux SA, Danaher Corporation, Dr. Fooke-Achterrath Laboratorien GmbH, DST Diagnostische Systeme & Technologien GmbH, Erba Group, Eurofins Scientific, EUROIMMUN Medizinische Labordiagnostika AG, HAL Allergy B.V., Hitachi, Ltd., HOB Biotech Group Corp., Ltd., HollisterStier by Jubilant Life Sciences Limited, HYCOR Biomedical, Lincoln Diagnostics, Inc., Minaris Medical America, Inc., Neogen Corporation, Omega Diagnostics Group PLC, Parkway Pantai Ltd., R-Biopharm AG, Romer Labs Division Holding GmbH by Royal DSM, ROXALL Medizin GmbH, Siemens AG, Stallergenes Greer International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..

The report offers valuable insights on the following aspects:

  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast for the Allergy Diagnostics Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Allergy Diagnostics Market?
  3. What is the competitive strategic window for identifying opportunities in the Allergy Diagnostics Market?
  4. What are the latest technology trends and regulatory frameworks in the Allergy Diagnostics Market?
  5. What is the market share of the leading vendors in the Allergy Diagnostics Market?
  6. Which modes and strategic moves are suitable for entering the Allergy Diagnostics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Frequently Asked Questions about the Global Allergy Diagnostics Market

What is the estimated value of the Global Allergy Diagnostics Market?

The Global Allergy Diagnostics Market was estimated to be valued at $5.92 Billion in 2023.

What is the growth rate of the Global Allergy Diagnostics Market?

The growth rate of the Global Allergy Diagnostics Market is 10.2%, with an estimated value of $11.8 Billion by 2030.

What is the forecasted size of the Global Allergy Diagnostics Market?

The Global Allergy Diagnostics Market is estimated to be worth $11.8 Billion by 2030.

Who are the key companies in the Global Allergy Diagnostics Market?

Key companies in the Global Allergy Diagnostics Market include ALK, Abelló A/S, Allergy Therapeutics PLC, Astra Biotech GmbH, Bausch & Lomb Incorporated, Biomérieux SA, Danaher Corporation, Dr. Fooke, Achterrath Laboratorien GmbH and DST Diagnostische Systeme & Technologien GmbH.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Allergy Diagnostics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of food allergies, allergic rhinitis, and asthma
5.1.1.2. Rising patient demand for in vitro diagnostic blood tests
5.1.1.3. Favorable reimbursement policies for allergy diagnostic tests
5.1.2. Restraints
5.1.2.1. Issues related to inaccuracy in allergic diagnosis
5.1.3. Opportunities
5.1.3.1. Advancement in allergic diagnosis products with enhanced sensitivity specificity and faster diagnosis
5.1.3.2. Increasing number of research and development initiatives for the development of drugs
5.1.4. Challenges
5.1.4.1. Lack of standardized diagnostic criteria coupled with limited availability of trained professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Allergy Diagnostics Market, by Type
6.1. Introduction
6.2. Drug Allergen
6.3. Food Allergen
6.4. Inhaled Allergen
7. Allergy Diagnostics Market, by Product Type
7.1. Introduction
7.2. Assay Kits
7.3. Consumables
7.4. Instruments
7.5.1. Immunoassay Analyzers
7.5.2. Luminometers
8. Allergy Diagnostics Market, by Test
8.1. Introduction
8.2. In-Vitro Tests
8.3. In-Vivo Tests
9. Allergy Diagnostics Market, by End User
9.1. Introduction
9.2. Academic Research Institutes
9.3. Diagnostic Laboratories
9.4. Hospital-Based Laboratories
10. Americas Allergy Diagnostics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Allergy Diagnostics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Allergy Diagnostics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. ModMed® Acquires Software from Xtract Solutions to build premier solution in allergy
13.3.1.2. Vimian Group Acquires Veterinary Allergy company in Denmark
13.3.2. New Product Launch & Enhancement
13.3.2.1. Amulet Launches to Bring Powerful detection out of the lab and into the hands of millions
13.3.2.2. Wellnow Allergy launches in liverpool to bring convenience to allergy testing and immunotherapy
13.3.3. Investment & Funding
13.3.3.1. This allergy drop startup raises $2M to bring at-home allergy testing to everyone
13.3.3.2. Home allergy testing company Nectar secures $16.5M in funding
13.3.4. Award, Recognition, & Expansion
13.3.4.1. AllerVie Health acquires Allergy, Sinus & Asthma family health center, densifies footprint in the villages, Florida
13.3.4.2. Siemens launches centre of excellence for immunoassay instrument R&D in Ireland
13.3.4.3. Reacta secures US patent for food allergy diagnostics
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. ALK-Abelló A/S
14.1.2. Allergy Therapeutics PLC
14.1.3. Astra Biotech GmbH
14.1.4. Bausch & Lomb Incorporated
14.1.5. Biomérieux SA
14.1.6. Danaher Corporation
14.1.7. Dr. Fooke-Achterrath Laboratorien GmbH
14.1.8. DST Diagnostische Systeme & Technologien GmbH
14.1.9. Erba Group
14.1.10. Eurofins Scientific
14.1.11. EUROIMMUN Medizinische Labordiagnostika AG
14.1.12. HAL Allergy B.V.
14.1.13. Hitachi, Ltd.
14.1.14. HOB Biotech Group Corp., Ltd.
14.1.15. HollisterStier by Jubilant Life Sciences Limited
14.1.16. HYCOR Biomedical
14.1.17. Lincoln Diagnostics, Inc.
14.1.18. Minaris Medical America, Inc.
14.1.19. Neogen Corporation
14.1.20. Omega Diagnostics Group PLC
14.1.21. Parkway Pantai Ltd.
14.1.22. R-Biopharm AG
14.1.23. Romer Labs Division Holding GmbH by Royal DSM
14.1.24. ROXALL Medizin GmbH
14.1.25. Siemens AG
14.1.26. Stallergenes Greer International AG
14.1.27. Tecan Trading AG
14.1.28. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. ALLERGY DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. ALLERGY DIAGNOSTICS MARKET SIZE, 2022 VS 2030
FIGURE 3. ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. ALLERGY DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
FIGURE 10. ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2022 VS 2030 (%)
FIGURE 12. ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 14. ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. ALLERGY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. ALLERGY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. ALLERGY DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. ALLERGY DIAGNOSTICS MARKET SIZE, BY DRUG ALLERGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ALLERGY DIAGNOSTICS MARKET SIZE, BY FOOD ALLERGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ALLERGY DIAGNOSTICS MARKET SIZE, BY INHALED ALLERGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 10. ALLERGY DIAGNOSTICS MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ALLERGY DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 14. ALLERGY DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ALLERGY DIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 17. ALLERGY DIAGNOSTICS MARKET SIZE, BY IN-VITRO TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. ALLERGY DIAGNOSTICS MARKET SIZE, BY IN-VIVO TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. ALLERGY DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. ALLERGY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. ALLERGY DIAGNOSTICS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 42. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 43. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 47. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 48. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 69. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 70. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 74. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 75. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 84. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 85. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 114. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 115. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 127. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 130. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 131. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 135. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 136. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 140. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 141. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 145. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 146. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 150. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 151. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 160. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 161. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 175. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 176. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 180. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 181. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 185. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 186. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 206. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 220. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 221. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. ALLERGY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 233. ALLERGY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 234. ALLERGY DIAGNOSTICS MARKET LICENSE & PRICING

Companies Mentioned

  • ALK-Abelló A/S
  • Allergy Therapeutics PLC
  • Astra Biotech GmbH
  • Bausch & Lomb Incorporated
  • Biomérieux SA
  • Danaher Corporation
  • Dr. Fooke-Achterrath Laboratorien GmbH
  • DST Diagnostische Systeme & Technologien GmbH
  • Erba Group
  • Eurofins Scientific
  • EUROIMMUN Medizinische Labordiagnostika AG
  • HAL Allergy B.V.
  • Hitachi, Ltd.
  • HOB Biotech Group Corp., Ltd.
  • HollisterStier by Jubilant Life Sciences Limited
  • HYCOR Biomedical
  • Lincoln Diagnostics, Inc.
  • Minaris Medical America, Inc.
  • Neogen Corporation
  • Omega Diagnostics Group PLC
  • Parkway Pantai Ltd.
  • R-Biopharm AG
  • Romer Labs Division Holding GmbH by Royal DSM
  • ROXALL Medizin GmbH
  • Siemens AG
  • Stallergenes Greer International AG
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...